National Center of Pharmacovigilance, Tunis, Tunisia.
Anatomo-pathological laboratory, Charles Nicolle Hospital, Tunis, Tunisia.
Ann Hepatol. 2018 January-February;17(1):144-152. doi: 10.5604/01.3001.0010.7546.
Effective prevention strategies require specific actions during the different phases of ischemia-reperfusion (I-R) injury. The objective of our study is to evaluate the effect of aqueous extract of Hypericum humifusum leaves (HHL) on liver I-R model in Rat.
Animals were subjected to 90 min of hepatic ischemia followed by reperfusion (120 min). HHL extract (25 mg/mL/kg) was injected 15 min before reperfusion. To evaluate the effect of HHL extract on I-R, we have monitored transaminases levels, Malondialdehyde (MDA) concentration, histological lesions (apoptosis and necrosis) and compared the results to a reference oxidant vitamin E.
The determination of total phenol extracts of HHL was 59.91 ± 0.35 mg of Gallic Acid/g dry plant material with higher antioxidant activity (91.73% ± 1.67) compared to vitamin E (87.42%). Using aqueous extract of HHL, we noted a significant decrease of AST and ALT [1129 UI (585/1995) and 768 UI (335/1375)] compared to no-treated group [5,585.5 UI (5,035/12,070) and 8,099.5 UI (5,040/12,326)] as a decrease in MDA content [85.7% protection (50.9/91.5)]. HHL extract reduce the damage induced by I-R of 48.7% (27/48.7) and 96.1% (95.7/96.5) for necrosis and apoptosis lesions respectively.
HHL aqueous extract have potential to protect liver from the damage effect induced by I-R better than vitamin E solution.
有效的预防策略需要在缺血再灌注(I-R)损伤的不同阶段采取具体措施。我们的研究目的是评估贯叶金丝桃叶水提物(HHL)对大鼠肝 I-R 模型的影响。
动物接受 90 分钟肝脏缺血,随后再灌注(120 分钟)。HHL 提取物(25mg/mL/kg)在再灌注前 15 分钟注射。为了评估 HHL 提取物对 I-R 的影响,我们监测了转氨酶水平、丙二醛(MDA)浓度、组织学损伤(凋亡和坏死),并将结果与抗氧化维生素 E 进行了比较。
HHL 总酚提取物的测定值为 59.91 ± 0.35mg 没食子酸/g 干植物材料,抗氧化活性(91.73% ± 1.67%)高于维生素 E(87.42%)。使用贯叶金丝桃叶水提物,我们注意到 AST 和 ALT 显著下降[1129 UI(585/1995)和 768 UI(335/1375)],与未处理组相比[5585.5 UI(5035/12070)和 8099.5 UI(5040/12326)],MDA 含量下降[85.7%保护(50.9/91.5)]。HHL 提取物将 I-R 引起的损伤减少了 48.7%(27/48.7)和 96.1%(95.7/96.5),分别用于坏死和凋亡损伤。
HHL 水提物在保护肝脏免受 I-R 损伤方面比维生素 E 溶液更有潜力。